Review
doi: 10.1038/nri1837.
Potent antibody therapeutics by design
Affiliations
- PMID: 16622479
- DOI: 10.1038/nri1837
Item in Clipboard
Review
Potent antibody therapeutics by design
Nat Rev Immunol.
2006 May.
Abstract
Antibodies constitute the most rapidly growing class of human therapeutics and the second largest class of drugs after vaccines. The generation of potent antibody therapeutics, which I review here, is an iterative design process that involves the generation and optimization of antibodies to improve their clinical potential.
Similar articles
-
Single-chain antibodies as new antithrombotic drugs.Semin Thromb Hemost. 2007 Mar;33(2):185-95. doi: 10.1055/s-2007-969033. Semin Thromb Hemost. 2007. PMID: 17340468 Review.
-
Targeted cancer therapy: conferring specificity to cytotoxic drugs.Acc Chem Res. 2008 Jan;41(1):98-107. doi: 10.1021/ar700108g. Epub 2007 Aug 18. Acc Chem Res. 2008. PMID: 17705444 Review.
-
Monoclonal and bispecific antibodies as novel therapeutics.Arch Immunol Ther Exp (Warsz). 2006 Mar-Apr;54(2):85-101. doi: 10.1007/s00005-006-0011-5. Epub 2006 Mar 24. Arch Immunol Ther Exp (Warsz). 2006. PMID: 16648969 Review.
-
Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.Acc Chem Res. 2008 Jan;41(1):108-19. doi: 10.1021/ar700093f. Epub 2007 Jul 31. Acc Chem Res. 2008. PMID: 17663526 Review.
-
Oligonucleotide, antibody and peptide therapeutics--from design to the clinic.Curr Opin Mol Ther. 2004 Apr;6(2):119. Curr Opin Mol Ther. 2004. PMID: 15195921 No abstract available.
Cited by
-
Development and Integration of Antibody-Drug Conjugate in Non-Hodgkin Lymphoma.Curr Oncol Rep. 2015 Sep;17(9):41. doi: 10.1007/s11912-015-0466-9. Curr Oncol Rep. 2015. PMID: 26194424 Review.
-
Antibody Afucosylation Augments CD16-Mediated Serial Killing and IFNγ Secretion by Human Natural Killer Cells.Front Immunol. 2021 Mar 16;12:641521. doi: 10.3389/fimmu.2021.641521. eCollection 2021. Front Immunol. 2021. PMID: 33796107 Free PMC article.
-
ASR488, a novel small molecule, activates an mRNA binding protein, CPEB1, and inhibits the growth of bladder cancer.Oncol Lett. 2020 Jul;20(1):850-860. doi: 10.3892/ol.2020.11593. Epub 2020 May 7. Oncol Lett. 2020. PMID: 32566012 Free PMC article.
-
Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity.MAbs. 2013 May-Jun;5(3):418-31. doi: 10.4161/mabs.24291. Epub 2013 Apr 8. MAbs. 2013. PMID: 23567210 Free PMC article.
-
Molecular Dynamics Simulation for Investigating Antigen-Antibody Interaction.Methods Mol Biol. 2023;2552:101-107. doi: 10.1007/978-1-0716-2609-2_4. Methods Mol Biol. 2023. PMID: 36346587
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
